Browse studies

Find your next paid study

9 recruiting studies matching your filters

Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)

The goal of this prospective, multicenter, open-label, blinded end-point pragmatic study is to evaluate an artificial intelligence (AI)-augmented echocardiogra…

MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseCirrhosis

Estimated

~$10 – $7,500

Kaiser PermanenteNCT07216859

Phase 2

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of Resmetirom for the Treatment of Metabolic Dysfunction- Associated Steatotic Liver Disease (MASLD) in People Living With Human Immunodeficiency Virus (HIV)

The purpose of this research study is to test the safety and effectiveness of the study drug, resmetirom, in participants with MASLD and HIV. This is a researc…

MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseHIV (Human Immunodeficiency Virus)

Estimated

~$10 – $8,750

Naga P. ChalasaniNCT07143968

Phase 2

Effect of Ketone Esters on Liver Fat and Metabolic Function in Adolescents and Young Adults With Overweight/Obesity and MASLD

The goal of this clinical trial is to determine whether ingestion of a ketone ester drink helps improve liver health and blood glucose control. Ketones are a t…

MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseObesityOverweight (BMI > 25)

Estimated

~$10 – $6,250

Washington University School of MedicineNCT07097506

Clinical Correlation Evaluation of the LIVERFAStTM Test for Diagnosing Important Liver Lesions of Fibrosis and Steatosis Against MR-based Liver Assessment, Magnetic Resonance Elastography (MRE) for Liver Fibrosis and MR-based Assessment of Steatosis, in Adult US Population.

This is a retrospective cross-sectional research intended to explore the utility of LIVERFASt in the clinical pathways for the detection of liver fibrosis and …

Liver Fibrosis Due to NASHMASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseAlcohol Liver Disease

Estimated

~$10 – $1,050

Fibronostics USA, IncNCT06797596

Observational

Pilot Test of Su Corazon Su Vida Among Mexican Origin Adults With MASLD

CVD is the leading cause of death among individuals with MASLD, a risk factor for liver cancer. In Southern Arizona, CVD and cancer (including liver and gastri…

CVD - Cardiovascular DiseaseMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease

Estimated

~$10 – $6,250

University of ArizonaNCT07298213

Observational

Food Insecurity and MASLD: A Fruit and Vegetable Intervention Study

This proposal addresses a critical gap in the understanding of the impact of household food insecurity (FI) on pediatric metabolic dysfunction-associated steat…

MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseFood Insecurity Among Children

Estimated

~$10 – $5,625

University of California, San FranciscoNCT07091539

Quantitative Ultrasound to Assess Steatotic Liver Disease in Children

This research study is being conducted to find out more about advanced ultrasound techniques to non-invasively evaluate liver disease in children. The investig…

MASLDMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease

Estimated

~$10 – $750

University of California, San DiegoNCT06706856

Pediatric MASLD and Food Insecurity

This proposal addresses a critical gap in our understanding of the impact of household food insecurity (FI) on pediatric metabolic dysfunction-associated steat…

MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseFood Insecurity

Estimated

~$10 – $675

University of California, San FranciscoNCT07090083

Observational

Development and Diagnostic Evaluation of a Novel Quantifiable Ultrasound Based Multi-parametric Biomarker for Hepatic Steatosis in Patients With Suspected MASLD ( LYNX )

The research study is considering a non-invasive way to measure the percentage of fat in the liver using ultrasound. This could help detect early signs of a ve…

MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseNAFLD - Non-Alcoholic Fatty Liver Disease

Estimated

~$10 – $7,500

ContextVision ABNCT07270601